NCT04046302View on ClinicalTrials.gov

Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women.

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

January 10, 2020

Study Completion Date

January 30, 2020

Conditions

IUD Insertion

Interventions

DRUG

Dinoprostone

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) self-inserted by participants 3 hours before scheduled IUD insertion appointment.

DRUG

placebo

one tablet of placebo self-inserted by participants 3 hours before scheduled IUD insertion appointment.

Trial Locations (1)

11231

faculty of medicine Cairo university, Giza

All Listed Sponsors

lead

Cairo University

OTHER

NCT04046302 - Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. | Biotech Hunter | Biotech Hunter